How Long Does Conformity Assessment Take in Malaysia? 2026 Guide

Table of Contents

Updated for 2026: Reflects revised MDA timeline guidance (CAB ~1.5 months; MDA 14–20 days for Class A; ~30 working days for Class B–D), the permanently confirmed Malaysia–Singapore HSA reliance arrangement (1 March 2026), removal of the 1-year marketing duration requirement for the verification route, MDSAP QMS recognition, Thai FDA as a new reference authority, and mandatory ePermit import permits effective 2 January 2026.
Quick Answer

Conformity assessment by a registered CAB in Malaysia targets approximately 1.5 months for the full assessment route and 30 working days for the verification route. After CAB assessment, MDA review targets 14–20 working days for Class A devices and approximately 30 working days for Class B, C, and D devices. Total end-to-end registration — including preparation, CAB, and MDA — typically runs 3–5 months for the verification route and 5–7 months for the full assessment route, assuming documentation is complete and clean at first submission.

Timeline is one of the first things manufacturers want to nail down when planning Malaysian market entry. When can we expect approval? How long should we allow for the CAB? What's the realistic end-to-end timeline, not just the official target?

The answers depend on three variables: your device classification, which assessment route you take, and how complete and consistent your documentation is at first submission. This guide gives you the full picture — official targets, realistic timelines, and what actually drives delays in the CAB conformity assessment process.

Key Takeaways

  • CAB full assessment targets approximately 1.5 months; verification route targets 30 working days.
  • MDA review targets 14–20 working days for Class A and approximately 30 working days for Class B, C, and D.
  • Total end-to-end timeline (preparation + CAB + MDA) is typically 3–5 months via verification route and 5–7 months via full assessment.
  • Since 1 March 2026, Singapore HSA-registered devices qualify permanently for the expedited verification route.
  • The 1-year marketing duration requirement for the verification route has been removed — only 12-month safety performance evidence is now required.
  • MDSAP certification is now recognised for QMS verification, potentially removing the need for separate ISO 13485 audits for participating manufacturers.
  • Thai FDA has been added as a recognised reference authority for the verification route in 2026.
  • Incomplete documentation at first CAB submission is the single most common cause of delays beyond the official targets.
The Two Routes

Full Assessment vs Verification: Timeline Comparison

The route your device takes through the CAB determines the largest variable in your timeline. The CAB and MDA play different roles in each route, but for timeline planning, the key figures are these.

Standard pathway
Full Assessment Route
Timeline breakdown
Document preparation 4–8 weeks
CAB assessment ~1.5 months
MDA review (Class B–D) ~30 working days
Import permit (ePermit) ~3 working days
Total (typical) 5–7 months

For devices without prior approval from a recognised authority. CAB conducts a full independent technical review of all documentation.

Expedited pathway
Verification Route
Timeline breakdown
Document preparation 4–6 weeks
CAB verification 30 working days
MDA review (Class B–D) ~30 working days
Import permit (ePermit) ~3 working days
Total (typical) 3–5 months

For devices with prior FDA, CE, HSA (permanently confirmed March 2026), TGA, Health Canada, Japan MHLW, or Thai FDA approval. CAB relies on reference approval.

Full Assessment Route vs Verification Route Malaysia CAB Timeline
Important note on timelines: These are target timelines from official MDA guidance, not guaranteed delivery times. Actual timelines depend heavily on documentation completeness, CAB workload, and the number of queries raised. A clean, complete first submission consistently achieves timelines close to the official targets. An incomplete submission can add months.
Class A

Class A Timeline: No CAB Required

Class A devices bypass the CAB entirely under the Medical Device (Exemption) Order 2024 and submit directly to the MDA via MeDC@St. This makes Class A the fastest registration pathway.

Stage Target timeline Notes
Document preparation 2–4 weeks Lighter documentation set — no CSDT or CAB certificate required
MDA review 14–20 working days Updated 2026 target from MDA guidance; previously stated as 30 working days
Import permit (ePermit) ~3 working days Mandatory from 2 January 2026 before first shipment
Total (typical) 6–10 weeks Assuming complete documentation at first submission
Class A sterile and measuring devices: These require additional documentation (sterilisation validation or metrological confirmation records) that can extend the preparation timeline. Factor in 1–2 extra weeks if your Class A device falls into either of these subtypes.
2026 Updates

What Changed in 2026 That Affects Your Timeline

2026 MDA Changes Summary Malaysia Conformity Assessment
HSA reliance permanently confirmed — verification route now the default for Singapore-registered devices 1 March 2026

Following a successful six-month pilot (September 2025 – February 2026), Malaysia permanently confirmed its regulatory reliance arrangement with Singapore's HSA on 1 March 2026. Devices on the Singapore Medical Device Register (SMDR) now qualify permanently for the 30-working-day verification route, making the EU MDR → Singapore HSA → Malaysia MDA cascade one of the most efficient pathways into ASEAN.

1-year marketing duration requirement removed

The previous verification route requirement that devices be marketed for at least one year in the reference country has been removed. Manufacturers now only need to demonstrate that within the past 12 months no deaths have been reported associated with the device and no safety recalls or field safety corrective actions have been initiated. This makes the verification route accessible earlier in a product's lifecycle than before.

MDSAP now recognised for QMS verification New 2026

The Medical Device Single Audit Program (MDSAP) certificate is now explicitly recognised by the MDA for quality management system verification. Manufacturers already participating in MDSAP — covering FDA, Health Canada, ANVISA, TGA, and PMDA — may not need a separate ISO 13485 audit, potentially reducing QMS-related preparation time.

Thai FDA added as recognised reference authority New 2026

Thailand's Food and Drug Administration (Thai FDA) has been added to the list of recognised reference authorities for the verification route. Manufacturers with Thai FDA approval can now access the expedited 30-working-day CAB verification pathway, opening the route for devices entering Malaysia via the Thai market.

Mandatory import permit via ePermit effective 2 January 2026 New 2026

A mandatory import permit must now be obtained via the ePermit/DagangNet system before any physical shipment. This adds approximately 3 working days post-approval and requires importers to have an active ePermit account set up in advance. Factor this into your commercial launch planning — shipments cannot proceed until the permit is issued.

Revised MDA review timeline for Class A

Updated MDA guidance now targets 14–20 working days for Class A device review, revised from the previously cited 30 working days. This reflects the simpler documentation set for Class A devices and their direct submission pathway without CAB involvement.

What Causes Delays

The Real Causes of Timeline Overruns

Official targets are achievable — but only when documentation is complete and consistent at first submission. These are the most common causes of timelines extending beyond the targets.

01
Incomplete documentation at first CAB submission

Missing documents, partial test reports, or unsigned certificates trigger CAB queries. Each query round typically adds 2–4 weeks to the assessment. Multiple rounds can push the CAB stage from 1.5 months to 3–4 months.

02
Inconsistent intended use across the dossier

Discrepancies between the intended use in the CSDT, labelling, IFU, and Declaration of Conformity are one of the most common CAB query triggers. Each inconsistency requires correction and resubmission of affected documents.

03
Expired certificates at submission

ISO 13485 certificates, CAB assessment reports, and reference authority approvals must all be within their validity period at submission. An expired certificate can halt the entire assessment until renewed documentation is provided.

04
Classification disputes

If the CAB determines the device has been misclassified, the assessment is paused while the classification issue is resolved. The MDA has a separate enhanced process for managing classification risk disputes between establishments and CABs. Resolving these disputes adds significant time.

05
Underestimating clinical evidence depth for the device class

Class C and D submissions require comprehensive clinical evidence — not summaries. Submitting Class B-level clinical documentation for a Class C device results in a CAB query requesting additional evidence, which can take months to compile if the data needs to be sourced from the manufacturer.

06
Not activating ePermit account before approval

Since 2 January 2026, import permits are mandatory before physical shipment. Importers who haven't set up their ePermit account in advance face delays in commercial launch even after registration approval is received. Set up the account early in the registration process, not after it completes.

How to Hit the Target

How to Protect Your Registration Timeline

Prepare to CAB-ready standard before submitting

The CAB stage is where most timelines are won or lost. A complete, consistent, and well-structured CSDT submitted to the CAB at first attempt consistently achieves close-to-target timelines. Build your documentation to the standard the CAB expects — not the minimum you think will pass.

Confirm classification before building the dossier

Starting documentation before confirming the correct device class is one of the most common causes of wasted time. A classification mistake discovered at the CAB stage can reset months of preparation. Confirm classification first, then build.

Check all certificate validity dates before submitting

Do a validity audit of every certificate in your dossier before submission — ISO 13485, reference authority approvals, test reports. Even a single expired document can halt the CAB assessment while renewal is arranged.

Use the verification route if you qualify

If your device has prior approval from FDA, CE, Singapore HSA (permanently confirmed March 2026), TGA, Health Canada, Japan MHLW, or Thai FDA — use the verification route. The 30-working-day CAB target versus the 1.5-month full assessment target represents a meaningful timeline saving across the full registration process.

Set up ePermit before registration completes

The mandatory import permit requirement (effective 2 January 2026) adds approximately 3 working days between approval and first shipment. Set up your ePermit/DagangNet account, train your logistics team, and nominate system users during the registration process — not after approval is received.

How We Can Help

Timeline Support from TT Medical

TT Medical manages the CAB and MDA stages end-to-end as your Local Authorised Representative — selecting the right registered CAB for your device type, preparing documentation to CAB-ready standard, managing query responses, and handling the full MDA submission and import permit coordination.

Route assessment — full vs verification
CSDT preparation to CAB-ready standard
CAB selection and assessment coordination
Local Authorised Representative (LAR) services
ePermit import permit coordination (2026)
Summary

Final Thoughts

Conformity assessment in Malaysia targets approximately 1.5 months for full assessment and 30 working days for the verification route. Adding MDA review, the total end-to-end timeline runs 3–5 months via verification and 5–7 months via full assessment — assuming documentation is complete at first submission.

The official targets are realistic, but they depend entirely on the quality of your first submission to the CAB. Every query round, every missing document, every inconsistency adds time. The manufacturers who consistently hit — or beat — official timelines are the ones who prepare their dossier to CAB-ready standard before submitting, not to a minimum viable standard.

If you're planning your Malaysian registration timeline and want a realistic assessment of where you stand, speak to our consultancy team. We'll review your current documentation status and give you a practical timeline estimate based on your device class and route eligibility.

FAQ

Frequently Asked Questions

The CAB targets approximately 1.5 months for the full assessment route and 30 working days for the verification route. These are target timelines from MDA guidance — actual timelines depend on documentation completeness and the number of queries raised. A complete, consistent dossier at first submission consistently achieves close-to-target timelines.
Updated 2026 MDA guidance targets 14–20 working days for Class A devices (submitted directly without CAB) and approximately 30 working days for Class B, C, and D devices after the CAB certificate is received. Because the CAB has already comprehensively pre-reviewed the dossier, MDA review is often faster in practice than the headline target suggests.
For a Class B device via the full assessment route, the total timeline — including preparation, CAB assessment, MDA review, and import permit — typically runs 5–7 months, assuming documentation is complete at first submission. Via the verification route (with prior FDA, CE, or HSA approval), the total typically runs 3–5 months.
Yes, significantly. The permanently confirmed Malaysia–Singapore HSA reliance arrangement (effective 1 March 2026) allows Singapore SMDR-registered devices to use the 30-working-day verification route rather than the full 1.5-month CAB assessment. This saves approximately 4–6 weeks at the CAB stage alone, making the EU MDR → Singapore HSA → Malaysia MDA cascade one of the most efficient ASEAN entry pathways.
The verification route requires prior approval from a recognised reference authority — FDA, EU CE, Singapore HSA, TGA Australia, Health Canada, Japan MHLW, or Thai FDA (new in 2026). If your device doesn't yet hold approval in any of these markets, you'll need to use the full assessment route. The 1-year marketing duration requirement has been removed, so newly approved devices in reference markets now qualify without waiting a year.
The most common causes are incomplete documentation at first CAB submission, inconsistent intended use across the dossier, expired certificates, classification disputes, and insufficient clinical evidence depth for higher-risk device classes. Each query round typically adds 2–4 weeks. A well-prepared, complete, and consistent dossier submitted on first attempt is the most reliable way to achieve timelines close to the official targets.

Share this post

Author

Picture of Melisa Leeau

Melisa Leeau

Melissa Leeau is the Founder of TT Training & Consulting and a medical device regulatory specialist with over 20 years of experience in regulatory compliance and market access across Southeast Asia. She advises global medical device and IVD companies on regulatory strategy, product registration, and compliance requirements in Malaysia, Indonesia, and Thailand.